Effect of Diabetes Mellitus on the Pharmacokinetics and Pharmacodynamics of Tuberculosis Treatment

Omamah Alfarisi; Vidya Mave; Sanjay Gaikwad; Tushar Sahasrabudhe; Geetha Ramachandran; Hemanth Kumar; Nikhil Gupte; Vandana Kulkarni; Sona Deshmukh; Sachin Atre; Swapnil Raskar; Rahul Lokhande; M.S. Barthwal; Arjun Lal Kakrani; Sandy Chon; Amita Gupta; Jonathan E. Golub; Kelly E. Dooley

doi:10.1128/aac.01383-18

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

Diabetes mellitus (DM) and tuberculosis (TB) are two common diseases with increasing geographic overlap and clinical interactions. The effect of DM and hemoglobin A1c (HbA1c) values on the pharmacokinetics (PK) and pharmacodynamics (PD) of anti-TB drugs remains poorly characterized.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Alfarisi et al. (2018) studied this question.

synapsesocial.com/papers/6a6fe132e71d69abee08406c https://doi.org/10.1128/aac.01383-18

View Full Paper

Ask AI

Bookmark

Share

Effect of Diabetes Mellitus on the Pharmacokinetics and Pharmacodynamics of Tuberculosis Treatment

Ask about this paper

Abstract

Discussion

Cite This Study

Effect of Diabetes Mellitus on the Pharmacokinetics and Pharmacodynamics of Tuberculosis Treatment

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading